Emerald Mutual Fund Advisers Trust’s Definium Therapeutics DFTX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.7M	Buy	+121,249	New	+$3M	0.2%	111

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's DFTX Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 121,249 shares worth $5.7M. The stake represents 0.2% of the portfolio and ranks #111 among its holdings.

362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Emerald Mutual Fund Advisers Trust held 121,249 shares of Definium Therapeutics worth $5.7M as of Q2 2026.
Definium Therapeutics was a new Emerald Mutual Fund Advisers Trust position in Q2 2026.
Definium Therapeutics made up 0.2% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #111 holding.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.